释放精度:对膜间皮瘤的有针对性的方法的审查
Mario Occhipinti1, Marta Brambilla2, Raimondo Di Liello3
1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Critical reviews in oncology/hematology
|August 19, 2024
概括
本综述探讨了多叶膜间皮瘤 (PM) 的先进治疗方法,包括免疫检查点抑制剂 (ICI). 针对遗传变化的精密瘤学策略为这种罕见的癌症的个性化医学提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 胸腔间皮瘤 (PM) 治疗传统上依赖于基于的化疗.
- 像免疫检查点抑制剂 (ICI) 这样的新兴疗法正在重塑治疗范式,正如Checkmate 743试验所证明的那样.
研究的目的:
- 审查目前和新兴的治疗策略,用于肺部间皮瘤.
- 突出精确瘤学和PM的生物标志物驱动方法的潜力.
主要方法:
- 关于最近的临床试验和研究结果的文献综述 胸膜间皮瘤.
- 对PM治疗相关的基因型和表型变化的分析.
主要成果:
- 免疫检查点抑制剂 (ICI) 代表了PM治疗的重大进展.
- 针对特定的变化,如CDKN2A损失,MMR和HR缺陷,对量身定制的疗法有很大的希望.
- 新的抑制剂和标,如美索林正在调查中.
结论:
- 个性化和精准医学方法对于改善多间皮瘤的结果至关重要.
- 克服患者选择,组合疗法和生物标志物识别方面的挑战对于临床实施至关重要.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:


